EBIXA, known generically as memantine, is a medication primarily used in the management of Alzheimer's disease, particularly in the moderate to severe stages. It operates as an NMDA receptor antagonist, which means it works by blocking the action of a chemical in the brain called glutamate that is believed to be linked to symptoms of Alzheimer's disease. By doing so, EBIXA helps to slow down the progression of the disease's symptoms, such as memory loss, difficulty thinking, and changes in behavior. It is important to note that while EBIXA can help manage symptoms, it is not a cure for Alzheimer's disease. The medication is usually prescribed by a healthcare professional and is available in tablet form or as an oral solution.